Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC β-lactamase in Brazil

References

1. Arakawa Y., Shibata N., Shibayama K., Kurokawa H., Yagi T., Fujiwara H., Goto M. 2000; Convenient test for screening metallo-beta-lactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microbiol 38:40–43
   [Google Scholar]
2. Bauernfeind A., Stemplinger I., Jungwirth R., Giamarellou H. 1996; Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother 40:221–224
   [Google Scholar]
3. Clarke B., Hiltz M., Musgrave H., Forward K. R. 2003; Cephamycin resistance in clinical isolates and laboratory-derived strains of Escherichia coli , Nova Scotia, Canada. Emerg Infect Dis 9:1254–1259 [CrossRef]
   [Google Scholar]
4. CLSI 2005 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard . CLSI document M7-A6, 6th edn. Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
5. Doi Y., Paterson D. L. 2007; Detection of plasmid-mediated class C beta-lactamases. Int J Infect Dis 11:191–197 [CrossRef]
   [Google Scholar]
6. Lartigue M. F., Poirel L., Poyart C., Réglier-Poupet H., Nordmann P. 2007; Ertapenem resistance of Escherichia coli . Emerg Infect Dis 13:315–317 [CrossRef]
   [Google Scholar]
7. Lincopan N., McCulloch J. A., Reinert C., Cassettari V. C., Gales A. C., Mamizuka E. M. 2005; First isolation of metallo- β -lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil. J Clin Microbiol 43:516–519 [CrossRef]
   [Google Scholar]
8. Lincopan N., Leis R., Vianello M. A., de Araújo M. R., Ruiz A. S., Mamizuka E. M. 2006; Enterobacteria producing extended-spectrum beta-lactamases and IMP-1 metallo-beta-lactamases isolated from Brazilian hospitals. J Med Microbiol 55:1611–1613 [CrossRef]
   [Google Scholar]
9. Liu Y. F., Yan J. J., Ko W. C., Tsai S. H., Wu J. J. 2008; Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan. J Antimicrob Chemother 61:1020–1023 [CrossRef]
   [Google Scholar]
10. Mammeri H., Nordmann P., Berkani A., Eb F. 2008; Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli . FEMS Microbiol Lett 282:238–240 [CrossRef]
    [Google Scholar]
11. Pasteran F. G., Otaegui L., Guerriero L., Radice G., Maggiora R., Rapoport M., Faccone D., Di Martino A., Galas M. 2008; Klebsiella pneumoniae carbapenenemase-2, Buenos Aires, Argentina. Emerg Infect Dis 14:1178–1180 [CrossRef]
    [Google Scholar]
12. Poirel L., Héritier C., Spicq C., Nordmann P. 2004; In vivo acquisition of high-level resistance to imipenem in Escherichia coli . J Clin Microbiol 42:3831–3833 [CrossRef]
    [Google Scholar]
13. Radice M., Cittadini R., Stortz M., Ruggiero M., Gutkind G., Vay C. 2007; Emergence of plasmid-mediated AmpC β -lactamases in ESBL-producing enterobacteria in Buenos Aires, Argentina. In Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy Washington, DC: 17–20 September 2007p– 131 Washington, DC: American Society for Microbiology;
    [Google Scholar]
14. Rapoport M., Monzani V., Pasteran F., Morvay L., Faccone D., Petroni A., Galas M. 2008; CMY-2-type plasmid-mediated AmpC beta-lactamase finally emerging in Argentina. Int J Antimicrob Agents 31:385–387 [CrossRef]
    [Google Scholar]
15. Villegas M. V., Lolans K., Correa A., Suarez C. J., Lopez J. A., Vallejo M., Quinn J. P. Colombian Nosocomial Resistance Study Group 2006; First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 50:2880–2882 [CrossRef]
    [Google Scholar]